A. J. KazimiChief Executive OfficerChief Executive Officer
Mr. Kazimi founded Cumberland Pharmaceuticals in 1999 and has served as Chief Executive Officer and Chairman of the Board of Directors since its inception. Prior to forming Cumberland, he served as President and Chief Operating Officer of Therapeutic Antibodies Inc., a biopharmaceutical company. During his 11 years with the company, Mr. Kazimi oversaw operations in three countries and played a key role in the company’s product development strategies, licensing and distribution agreements, and the raising of more than $100 million through equity and debt financings, as well as its initial public offering. Earlier in his career, he worked at Brown-Forman Corporation, rising through a series of management positions. Mr. Kazimi currently serves on the board of directors for the Nashville Health Care Council, an industry association representing the largest concentration of healthcare companies in the United States and has served on the board for Aegis Toxicology Sciences Corporation, a federally certified forensic toxicology laboratory. He also serves as Chairman and Chief Executive Officer of Cumberland Emerging Technologies, Inc. (CET). He holds a B.S. from the University of Notre Dame and an M.B.A. from the Vanderbilt Owen Graduate School of Management.
James L. HermanExecutive Vice President, National Accounts & Chief Compliance OfficerExecutive Vice President, National Accounts & Chief Compliance Officer
As Executive Vice President of National Accounts, Mr. Herman handles all national sales, including wholesalers and retail chain buying offices, managed care home offices and federal government accounts. He also oversees corporate compliance efforts. Previously, he was with Solvay Pharmaceuticals where he served as Director of Managed Care, as well as Director of Trade Affairs and Customer Service. Earlier in his career, Mr. Herman spent eight years with Schwarz Pharma, where he held national sales leadership positions. He holds a B.S. from Indiana University and an M.B.A. from Cardinal Stritch University.
Chris BittermanVice President of Sales & MarketingVice President of Sales & Marketing
Mr. Bitterman joined Cumberland in 2018 with a distinguished career in Acute Care and pharmaceutical sales management spanning over 25 years. Highlights include his roles as National Sales Director for Daiichi Sankyo and Regional Sales Director for Sanofi Aventis. Prior to Cumberland, Mr. Bitterman was employed at Lupin Pharmaceuticals as National Sales Director, leading the commercialization efforts for their Women’s Healthcare portfolio. As Cumberland’s Hospital Sales Director, he is responsible for leading our veteran Hospital Sales division, the development & execution of team business priorities, and delivering the financial objectives for our Hospital products. A native of Detroit, Michigan, Mr. Bitterman earned his bachelor’s and master’s degree in Business from Central Michigan University.
Todd AnthonyVice President, Organizational DevelopmentVice President, Organizational DevelopmentMr. Anthony joined our company in 2010 and is Vice President, Organizational
Development. He is responsible for all training activities related to product knowledge and
selling skills for our Sales Organization, as well as sales management, corporate training, and
leadership development. He began his pharmaceutical career with Berlex Laboratories Inc. in
1991 and spent 19 years at that company which is now Bayer HealthCare Pharmaceuticals
following the 2006 acquisition of Schering AG. While there he held positions of increasing
responsibility including roles in Sales, Sales Training, Sales Management and Corporate
Management/Leadership development. He has a BSN degree from D’Youville College in Buffalo,
Tan Cheow ChoonSenior Director, International BusinessSenior Director, International Business
Mr. Tan is the Senior Director of International Business Development for Cumberland Pharmaceuticals. His responsibilities include identifying new partnership opportunities and managing those relationships in the Asian market. Prior to joining Cumberland, he was Vice President of Southeast Asia & Korea at Hospira Inc. His career also includes roles in banking & finance with the United Overseas Bank, Singapore as well as the establishment, development & management of pharmaceutical partnerships across Asia as General Manager, Asia for Mayne & Faulding Pharmaceutical of Australia. Mr. Tan is an Accountant, earning his Bachelor of Accountancy from the National University of Singapore and an MBA from Monash University in Australia.
Barry L. LeeSenior Director, MarketingSenior Director, Marketing
In his role as Senior Director, Hospital Products, Mr. Lee is responsible for all marketing activities associated with the commercialization of Caldolor®, the company’s intravenous formulation of ibuprofen. Prior to joining the company in 2008, he spent 24 years with Bayer Healthcare Pharmaceuticals, Inc. There he held a variety of pharmaceutical sales and marketing positions and, most notably, was responsible for the launch of Yasmin® in 2001—one of the most successful industry product launches at that time. He earned a B.S. degree from Texas A&M University.
Kenny AcevedoSenior Director, Field SalesSenior Director, Field Sales
Prior to joining Cumberland 2011, Mr. Acevedo served in several roles including Hospital District Manager and Senior District Manager for Novartis Pharmaceuticals. Mr. Acevedo has been involved in the launching of several noteworthy pharmaceutical products. He also spent 5 years at ICN Pharmaceuticals as Regional Director for the West Coast. He is a graduate of New York State University at Stony Brook and he also received his Master’s in Health Administration from Long Island University.
Adam MostafaManaging DirectorManaging Director
In his role as a consulting Managing Director, Mr. Mostafa is responsible for managing our investment banking activities and supporting our institutional investor interactions. Adam is an experienced biopharmaceutical investment banker who has worked for over 17 years in corporate finance. Prior to joining Cumberland in 2017, Mr. Mostafa worked on Wall Street at Cantor Fitzgerald & Co. as Managing Director, Healthcare Investment Banking. There, he was involved predominantly in financing life sciences companies in the specialty pharmaceutical and biotechnology sectors. He also served as a senior healthcare investment banker at both Needham & Company and CRT Capital, where at the latter he was also involved in life sciences private equity investments. Earlier in his career, Adam was a portfolio management associate at AQR Capital and a healthcare investment banking analyst at Salomon Smith Barney. Mr. Mostafa graduated from Brown University with a degree in Economics.
John HammChief Financial OfficerChief Financial OfficerIn his role as Director Finance & Accounting and Chief Financial Officer, Mr. Hamm manages all of Cumberland’s finance and accounting activities while continuing to oversee corporate development and legal matters. He has more than 25 years of executive finance and accounting experience, including 20 years in health care. Prior to joining Cumberland in 2019, Hamm served in senior executive positions in the health care, broadcasting and telecom industries. Hamm is the former Chief Operating Officer at HealthSpring and Chief Financial Officer for their pharmacy business. HealthSpring, a managed care organization, now operates as Cigna-HealthSpring. John holds both a bachelor's and a master’s degree in business administration with an emphasis in accounting.